Target intelligence / Profile preview

Phospholipase A2 group XG, pseudogene (PLA2G10GP)

Target: PLA2G10GP
Molecular classification: Other (pseudogene)

Overview

Phospholipase A2 group XG, pseudogene (PLA2G10GP) is a genetic sequence categorized as a pseudogene. Pseudogenes are segments of DNA that resemble known genes but are non-functional due to mutations or lack of regulatory elements required for expression. PLA2G10GP mimics the sequence of phospholipase A2 group X, an active enzyme within the phospholipase A2 superfamily. However, the pseudogene itself does not produce a functional protein, does not participate in enzymatic or signaling pathways, and is not considered a therapeutic target or biomarker in disease, nor is it associated with drug interactions or therapeutic safety concerns[1].

Other names: PLA2G10GPPhospholipase A2 group XG, pseudogene

Beyond the preview

Go deeper on Phospholipase A2 group XG, pseudogene (PLA2G10GP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phospholipase A2 group XG, pseudogene (PLA2G10GP).

Explore the full profile